HLA, PTPN22 and PD-1 associations as markers of autoimmunity in neuromyelitis optica

Mult Scler. 2012 Jan;18(1):23-30. doi: 10.1177/1352458511417480. Epub 2011 Sep 9.

Abstract

Background: Neuromyelitis optica (NMO) is a disease with autoimmune characteristics. A genetic autoimmune dependency for NMO has not been clarified in detail.

Objective: To investigate immunogenetic aspects of NMO.

Methods: Forty-one patients with NMO and 42 patients with multiple sclerosis (MS) were diagnosed in a population-based Caucasian cohort. HLA DQA1, DQB1, and DRB1 alleles were determined. Polymorphisms in programmed death 1 (PD-1) PD-1.3 G/A and protein tyrosine phosphatase non-receptor 22 (PTPN22) 1858 C/T were genotyped.

Results: In the NMO group 15% had other autoimmune disorders and 39% had family occurrence of autoimmunity, comparable to MS. A higher frequency of a family history (17%) of NMO and MS was found in the NMO group (p < 0.026). The frequency of HLA-DQB1*0402 allele was increased in NMO (p after Bonferroni correction, cp < 0.035) and the HLA-DRB1*15 and DQB1*06 alleles were increased in MS (cp < 0.0027, cp < 0.01), compared to controls. No associations of the PTPN22 1858 T were detected. The PD-1.3A allele was increased both in NMO (p < 0.0023) and in MS patients (p < 0.028) compared to controls.

Conclusion: Patients with NMO had frequent co-existence of autoimmunity and family occurrence of NMO and MS. The PD-1.3A allele was associated with NMO. The data suggest genetic autoimmune dependency of NMO.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Autoantibodies / blood
  • Autoantibodies / immunology
  • Autoantigens / immunology
  • Autoimmunity / genetics*
  • Autoimmunity / immunology
  • Biomarkers / analysis
  • Female
  • Fluorescent Antibody Technique
  • Gene Frequency
  • Genetic Predisposition to Disease
  • HLA-DQ beta-Chains / genetics*
  • Humans
  • Male
  • Middle Aged
  • Multiple Sclerosis / complications
  • Multiple Sclerosis / genetics
  • Neuromyelitis Optica / complications
  • Neuromyelitis Optica / genetics
  • Neuromyelitis Optica / immunology*
  • Polymorphism, Genetic
  • Programmed Cell Death 1 Receptor / genetics*
  • Protein Tyrosine Phosphatase, Non-Receptor Type 22 / genetics*
  • Radioimmunoassay
  • Young Adult

Substances

  • Autoantibodies
  • Autoantigens
  • Biomarkers
  • HLA-DQ beta-Chains
  • HLA-DQB1 antigen
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • PTPN22 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 22